EUVIMEDEUVIMED entdecken
Open Access

Pharmacological evaluation of phage-antibiotic synergism against clinical isolates of multi-drug resistant Staphylococcus aureus in a burn-induced infection mouse model

Syed Damin Abbas Hamdani, Mustafeez Mujtaba Babar, Huma Sajjad, Alvina Gul, Mudassira Zahid, Tausif Ahmed Rajput, Aneeqa Noor, Madiha Ahmed, John J Dennehy

Brazilian Journal of Microbiology · 2025

DOI: 10.1007/s42770-025-01762-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brazilian Journal of Microbiology, 2025. Verfasst von Syed Damin Abbas Hamdani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, 44000, Pakistan. Hauptthemen laut MEDLINE: Burns, Anti-Bacterial Agents, Staphylococcal Infections, Phage Therapy. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug resistant Staphylococcus aureus (MDRSA) is a superbug that shows enormous resistance to many antibiotics. Identified by the World Health Organization as one of the high priority pathogens, there is an urgent need to develop new antibiotic strategies against MDRSA. One such approach is the use of bacteriophages as antimicrobial agents. When bacteriophages are used in combination with antibiotics, phage-antibiotic synergism (PAS) effectively inhibits bacteria. The current study evaluated various phage-antibiotic combinations to determine the optimal PAS activity against 10 clinical isolates of MDRSA, both in vitro and in a burn-induced wound infection mouse model (n = 3/ group). A novel phage, SDAH-01, was isolated locally and characterized. After establishing in vitro antibacterial activity, a burn-induced skin infection mouse model was used to evaluate PAS activity. Wound contraction, bacterial load, and histopathological changes were observed over the duration of treatment. Inflammatory markers (IL-6, TNF-α, VEGF) were evaluated using immunohistochemical methods. Optimal combinations of phages with amoxicillin, azithromycin, and ciprofloxacin significantly inhibited bacterial growth and promoted wound healing as compared to monotherapies. By Day 14, phage-amoxicillin resulted in a 6-log reduction in bacterial load, showing the maximum activity. Similarly, phage-azithromycin and phage-ciprofloxacin combinations showed significant reductions in comparison to monotherapies depicting their improved efficacy. Phage-antibiotic groups also exhibited highest rates of wound contraction, with phage-amoxicillin and phage-azithromycin demonstrating 55% and 50% contraction respectively. Histological analysis indicated improved tissue regeneration and reduced inflammation with combination therapy. This study demonstrates the potential of PAS in effective management of MDRSA infections, suggesting its potential clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BurnsAnti-Bacterial AgentsStaphylococcal InfectionsPhage TherapyMethicillin-Resistant Staphylococcus aureusBacteriophagesStaphylococcus PhagesWound InfectionStaphylococcus aureusAnimalsMiceDisease Models, AnimalDrug Resistance, Multiple, BacterialDrug SynergismHumansCiprofloxacinAmoxicillinWound HealingAzithromycinMale

Stichwörter der Autor:innen

Antibiotic resistanceBacteriophage therapy, PASBurn wound infectionMRSAPhage-antibiotic combination

Substanzen

Anti-Bacterial AgentsCiprofloxacinAmoxicillinAzithromycin

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, 44000, Pakistan.
  • Department of Basic Medical Sciences, Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, 44000, Pakistan. mustafeez.babar@fulbrightmail.org.
  • Department of Plant Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, 44000, Pakistan.
  • Department of Pathology, Rawalpindi Medical University, Rawalpindi, 46000, Pakistan.
  • Department of Pharmaceutical Chemistry, Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, 44000, Pakistan.
  • Department of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering, National University of Sciences and Technology, Islamabad, 44000, Pakistan.

Zitieren

APA

Hamdani, S. D. A., Babar, M. M., Sajjad, H., Gul, A., Zahid, M., Rajput, T. A., Noor, A., Ahmed, M., & Dennehy, J. J. (2025). Pharmacological evaluation of phage-antibiotic synergism against clinical isolates of multi-drug resistant Staphylococcus aureus in a burn-induced infection mouse model. Brazilian Journal of Microbiology. https://doi.org/10.1007/s42770-025-01762-2

Vancouver

Hamdani SDA, Babar MM, Sajjad H, Gul A, Zahid M, Rajput TA, et al. Pharmacological evaluation of phage-antibiotic synergism against clinical isolates of multi-drug resistant Staphylococcus aureus in a burn-induced infection mouse model. Brazilian Journal of Microbiology. 2025. doi:10.1007/s42770-025-01762-2

BibTeX
@article{Hamdani2025,
  author = {Hamdani, Syed Damin Abbas and Babar, Mustafeez Mujtaba and Sajjad, Huma and Gul, Alvina and Zahid, Mudassira and Rajput, Tausif Ahmed and Noor, Aneeqa and Ahmed, Madiha and Dennehy, John J},
  title = {Pharmacological evaluation of phage-antibiotic synergism against clinical isolates of multi-drug resistant Staphylococcus aureus in a burn-induced infection mouse model},
  journal = {Brazilian Journal of Microbiology},
  year = {2025},
  doi = {10.1007/s42770-025-01762-2}
}
Kostenlos starten →